The Anti-Fasciolasis Properties of Silver Nanoparticles Produced by Trichoderma harzianum and Their Improvement of the Anti-Fasciolasis Drug Triclabendazole

Nanotechnology Applications in Medicine

(2018) Elena Angeli et al.   TUMORI

Enhanced Efficacy and Broadening of Antibacterial Action of Drugs via the Use of Capped Mesoporous Nanoparticles

(2013) Núria Mas et al.   CHEMISTRY-A EUROPEAN JOURNAL

Interaction of silver nanoparticles withEscherichia coliand their cell envelope biomolecules

(2013) Mohammad Azam Ansari et al.   JOURNAL OF BASIC MICROBIOLOGY

Size-dependent antibacterial activities of silver nanoparticles against oral anaerobic pathogenic bacteria

(2013) Zhong Lu et al.   JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE

Surface plasmon enhanced drug efficacy using core–shell Au@SiO2 nanoparticle carrier

(2013) Zhiqin Chu et al.   Nanoscale

Fungus-Mediated Green Synthesis of Silver Nanoparticles Using Aspergillus terreus

(2011) Guangquan Li et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Antileishmanial effect of silver nanoparticles and their enhanced antiparasitic activity under ultraviolet light

(2011) Adil Allahverdiyev et al.   International Journal of Nanomedicine

Development of an egg hatch assay for the diagnosis of triclabendazole resistance in Fasciola hepatica: Proof of concept

(2011) I. Fairweather et al.   VETERINARY PARASITOLOGY

Development of azithromycin–PLGA nanoparticles: Physicochemical characterization and antibacterial effect against Salmonella typhi

(2010) Ghobad Mohammadi et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Audit of stool analysis results to ensure the prevalence of common types of intestinal parasites in Riyadh region, Saudi Arabia

(2010) A.M. Eligail et al.   SAUDI JOURNAL OF BIOLOGICAL SCIENCES

Antimicrobial effect of silver nanoparticles produced by fungal process on cotton fabrics

(2009) M.H. El-Rafie et al.   CARBOHYDRATE POLYMERS

Blue orange light emission from biogenic synthesized silver nanoparticles using Trichoderma viride

(2009) Mohammed Fayaz et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Triclabendazole progress report, 2005–2009: an advancement of learning?

(2009) I. Fairweather   JOURNAL OF HELMINTHOLOGY

Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs

(2009) L. Alvarez et al.   VETERINARY PARASITOLOGY

Targeted Drugs and Nanomedicine: Present and Future

(2008) Paul Debbage   CURRENT PHARMACEUTICAL DESIGN

Pharmacokinetic behavior in sheep and cattle of 5-chloro-2-(methylthio)-6-(1-naphthyloxy)-1H-benzimidazole, a new fasciolicide agent

(2008) N. RAMÍREZ et al.   JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS

Genetic characterisation of Fasciola samples from different host species and geographical localities revealed the existence of F. hepatica and F. gigantica in Niger

(2008) H. Ali et al.   PARASITOLOGY RESEARCH

Fasciola hepatica: Tegumental alterations in adult flukes following in vitro and in vivo administration of artesunate and artemether

(2007) Jennifer Keiser et al.   EXPERIMENTAL PARASITOLOGY